Intrinsic Value
Taysha Gene Therapies, Inc. (TSHA)
$2.35
-0.18 (-7.11%)
| Enterprise Value | - |
|---|---|
| Net Debt | -83.28 |
| Equity Value | - |
| Shares Outstanding | 116.12 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt